Abstract 8000: Polygenic Risk Identifies Early-Life LDL-C Elevation and Highlights Treatment Opportunities in a U.S. Clinical Population
Introduction: Hypercholesterolemia (HC) is a major driver of cumulative atherosclerotic cardiovascular disease (ASCVD) risk across the lifespan. While polygenic risk scores (PRS) for HC may complement monogenic familial hypercholesterolemia (FH) testing, their relationship to early-life LDL-C burden and clinical man...